Anupam Basu

Multi-Omics Analysis of Red Blood Cells Reveals Molecular Pathways Underlying Thalassemia Severity Beyond Globin Gene Mutations

This study identifies six molecular pathways associated with thalassemia severity in patients with identical mutations, highlighting non-genetic factors contributing to disease outcomes.

Alpha globin gene deletions in amelioration of clinical severity in beta haemoglobinopathy subjects with the β0/β+ genotype

The paper investigates how alpha globin gene deletions affect clinical severity in beta-thalassemia patients with specific genotypes, finding significant amelioration in the β+/β0 genotype.

Drug repurposing: Hydroxyurea therapy improves the transfusion-free interval in HbE/beta thalassemia major patients with Xmn1 polymorphism

Burdwan University Thalassemia Severity (BUTS) Scoring System: A numerical Method For Defining the Clinicopathological status of Thalassaemia Patient

The paper introduces a severity scoring system for beta-haemoglobinopathies using clinical parameters to classify patients as severe or non-severe, achieving 94% accuracy in a cohort of Eastern Indian patients.